Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | T370_A371delinsC |
Impact List | indel |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR2 T370_A371delinsC results in a deletion of a threonine (T) and an alanine (A) from aa 370 to aa 371 within the extracellular domain of the Fgfr2 protein, combined with the insertion of a cysteine (C) at the same site (UniProt.org). T370_A371delinsC has been identified in the scientific literature (PMID: 34480077), but has not been biochemically characterized and therefore, its effect on Fgfr2 protein function is unknown (PubMed, Jul 2024). |
Associated Drug Resistance | |
Category Variants Paths |
FGFR2 mutant FGFR2 T370_A371delinsC |
Transcript | NM_000141.5 |
gDNA | chr10:g.121515291_121515296delinsACA |
cDNA | c.1108_1113delinsTGT |
Protein | p.T370_A371delinsC |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000141.5 | chr10:g.121515291_121515296delinsACA | c.1108_1113delinsTGT | p.T370_A371delinsC | RefSeq | GRCh38/hg38 |
NM_001320658.2 | chr10:g.121515291_121515296delinsACA | c.1108_1113delinsTGT | p.T370_A371delinsC | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR2 T370_A371delinsC | intrahepatic cholangiocarcinoma | predicted - sensitive | Lenvatinib | Case Reports/Case Series | Actionable | In a clinical case study, Lenvima (lenvatinib) treatment resulted in a reduction in tumor burden and ongoing response at 11.6 months in a patient with intrahepatic cholangiocarcinoma harboring FGFR2 T370_A371delinsC (PMID: 34480077). | 34480077 |